CN106580584A - Sickbed with double disinfecting function - Google Patents
Sickbed with double disinfecting function Download PDFInfo
- Publication number
- CN106580584A CN106580584A CN201710069884.XA CN201710069884A CN106580584A CN 106580584 A CN106580584 A CN 106580584A CN 201710069884 A CN201710069884 A CN 201710069884A CN 106580584 A CN106580584 A CN 106580584A
- Authority
- CN
- China
- Prior art keywords
- sick bed
- sickbed
- poly
- gluco
- mattress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000249 desinfective effect Effects 0.000 title abstract 6
- 239000000463 material Substances 0.000 claims abstract description 16
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 230000009977 dual effect Effects 0.000 claims description 16
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 229940088710 antibiotic agent Drugs 0.000 claims description 11
- 230000003115 biocidal effect Effects 0.000 claims description 11
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 7
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 2
- 244000182067 Fraxinus ornus Species 0.000 claims description 2
- 235000002917 Fraxinus ornus Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 235000007230 Sorghum bicolor Nutrition 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 19
- 241000700605 Viruses Species 0.000 abstract description 10
- 241000894006 Bacteria Species 0.000 abstract description 9
- 206010011409 Cross infection Diseases 0.000 abstract description 4
- 206010029803 Nosocomial infection Diseases 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 229910001220 stainless steel Inorganic materials 0.000 abstract description 2
- 239000010935 stainless steel Substances 0.000 abstract description 2
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003828 vacuum filtration Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 229910052603 melanterite Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
- A61G7/05—Parts, details or accessories of beds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nursing (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Invalid Beds And Related Equipment (AREA)
Abstract
The invention particularly discloses a sickbed with a double disinfecting function. The sickbed comprises a sickbed body, a mattress and a pillow, the sickbed further comprises an ultraviolet disinfecting system which comprises a power source line box, a switch set, an ultraviolet lamp device box, a universal movable arm and an ultraviolet lamp set, the sickbed body is made of stainless steel, the pillow comprises a palm layer and a wrapping sponge layer, and the mattress comprises springs, a palm layer and a wrapping sponge layer. The sickbed comprises the ultraviolet disinfecting system. The wrapping sponge layer of each of the mattress and the pillow is made of an antibacterial material. The ultraviolet disinfecting system and the antibacterial material jointly generate double disinfecting effect, disease infection and cross infection caused by breeding of bacteria and viruses on the sickbed can be avoided, health of accompanying personnel can be guaranteed, and the accompanying personnel can be avoided being infected with bacteria and viruses after contacting with the sickbed. The sickbed can be applied in medical industry or families and has great application value and market prospect.
Description
Technical field
The present invention relates to new type medical equipment field, in particular it relates to a kind of sick bed with dual sterilizing function.
Background technology
Sick bed is that, with the most medical apparatus and instruments of contact patients, general ward the inside has multiple sick beds, that is, can
Live in multiple patients.Patient typically can carry the bacterial viruses of some diseases, and multiple patients live together, and just have various thin
Bacterium virus.The surface of sick bed is usually synthetic plastic leather, is also easier to grow various microorganisms.Hospital is general only can be to disease
Bedding on bed carries out cleaning and sterilizing, and seldom can carry out disinfection cleaning to sick bed, after so different patient's uses, Jiu Huiliu
Under various bacterial viruses.Existing sick bed can all have substantial amounts of bacterial viruses to grow, and the sterilization to sick bed is also usually ignored by hospital
Sterilization, so may result in cross infection, and to the recovery band of patient new trouble is carried out.
The content of the invention
For the deficiency in prior art, the present invention provides a kind of sick bed with dual sterilizing function, has solved above-mentioned
Technical problem.
The present invention is achieved by the following technical programs：
Provide a kind of sick bed with dual sterilizing function in embodiments of the invention, including sick bed main body, mattress and
Medicated pillow is constituted, and the sick bed also includes uv disinfection system, and uv disinfection system includes power cord box, switches set, uviol lamp dress
Put box, Universal active arm, uviol lamp group；The sick bed main body is made up of rustless steel, and the medicated pillow includes Petiolus Trachycarpi layer and parcel sea
Continuous layer, the sick bed mattress includes spring, Petiolus Trachycarpi layer and parcel spongy layer.
Relative to prior art, beneficial effects of the present invention：One kind that the above embodiment of the present invention is provided has dual
The sick bed of sterilizing function, the sick bed of the present invention also includes uv disinfection system, and the parcel spongy layer of the medicated pillow of the present invention is antibacterial
Material is made, and the parcel spongy layer of the sick bed mattress is made up of anti-biotic material.The uv disinfection system and antibacterial material of the present invention
Material collectively constitutes dual disinfective action, and the bacterial viruses that can avoid patient itself grow in sick bed, affects the rehabilitation of patient；
Different patients can be avoided to use after same sick bed, the bacterial viruses of itself are grown in sick bed, be transmitted to next patient,
Cause cross infection.The dual disinfective action of the sick bed of the present invention, it is also possible to ensure the health of entourage, it is to avoid entourage
Contact sick bed postoperative infection bacterial viruses.The antibacterial effect of the antibacterial sponge that the present invention is used is preferable, under equal condition of culture,
The clump count of the escherichia coli, Salmonella and staphylococcus aureuses of 2 kinds of sponges differs 3 orders of magnitude, the training of antibacterial sponge
The clump count of escherichia coli, Salmonella and staphylococcus aureuses is respectively 6.4 × 10 in foster diluent2、8.1×102With
3.9×102Individual mL-1；The sick bed with dual disinfective action of the present invention, can apply to vast medical industry or
Family, is with a wide range of applications and market prospect.
Description of the drawings
Accompanying drawing herein is merged in description and constitutes the part of this specification, shows the enforcement for meeting the present invention
Example, and be used to explain the principle of the present invention together with description.
Fig. 1 is the structural representation of the present invention.
Wherein：Sick bed main body -60, mattress -61, medicated pillow -62, power cord box -70, switches set -71, ultraviolet lamp device box -
72, Universal active arm -73, uviol lamp group -74.
Specific embodiment
Here exemplary embodiment will be illustrated in detail, its example is illustrated in the accompanying drawings.Explained below is related to
During accompanying drawing, unless otherwise indicated, the same numbers in different accompanying drawings represent same or analogous key element.Following exemplary embodiment
Described in embodiment do not represent and the consistent all embodiments of the present invention.Conversely, they be only with it is such as appended
The example of the consistent apparatus and method of some aspects described in detail in claims, the present invention.
A kind of sick bed with dual sterilizing function is provided in embodiments of the invention, Fig. 1 is that the structure of the present invention is shown
It is intended to, as shown in figure 1, constituting including sick bed main body, mattress and medicated pillow, the sick bed also includes uv disinfection system, ultraviolet to disappear
Malicious system includes power cord box, switches set, ultraviolet lamp device box, Universal active arm, uviol lamp group；The sick bed main body is stainless
Steel is made, and the medicated pillow includes Petiolus Trachycarpi layer and parcel spongy layer, and the sick bed mattress includes spring, Petiolus Trachycarpi layer and parcel sponge
Layer.When use, switches set is adjusted as needed.
Preferably, the switches set includes time controller and uviol lamp gear controller, ultraviolet in the uviol lamp group
The number of lamp is 3-5.
It is highly preferred that the number of uviol lamp is 3 in the uviol lamp group.
Preferably, the parcel spongy layer of the medicated pillow is made up of anti-biotic material, and the parcel spongy layer of the sick bed mattress is
Anti-biotic material is made, and in embodiment provided by the present invention, specifically illustrates sick bed of the present invention with dual sterilizing function
The preparation method of the anti-biotic material for being adopted, the preparation method of the anti-biotic material is comprised the following steps：
One kind has antibacterial antioxidative anti-biotic material, and the anti-biotic material includes poly- gluco-manno sugar, oligochitosan, zinc ion
It is polymerized with montmorillonite；
Poly- gluco-manno sugar is the polymer of monosaccharide, and sugared its molecular size range thousand of different poly- gluco-mannos of originating differs from ten thousand
Not, and whether the molecular size range of poly- gluco-manno sugar stable to the combination of polymer, and the yield of polymer has important
Affect, the selection of poly- gluco-manno glycan molecule amount is also a difficult point of the present invention.Mean square radius of gyration is to characterize linear polymerization
The constant of thing molecular dimension, is also the dimensional parameters for representing a polymer, fine for the half of the suitable size of subsequent experimental selection
Dimension has important references meaning.
Preferably, its preparation method is comprised the following steps：
S1. oligochitosan-iron complexes are prepared：Take oligochitosan and be dissolved in 1.5% acetum (1.5%, v/v), magnetic agitation
Under the conditions of add appropriate FeSO4·7H2O powder, it is 6.0 to adjust pH with the sodium acetate of 5g/L, persistently stirs 10～12h to flat
Weighing apparatus, adds volume ratio to be 25:24:1 acetone：Ethanol：Isoamyl alcohol mixed liquor, obtains bulk precipitation；Vacuum filtration is isolated heavy
Starch, first with 75% ethanol wash precipitate 3 times, after with absolute ethanol washing precipitate 3 times, again vacuum filtration remove residual wash
Wash agent and unreacted ion, repeat with absolute ethanol washing 3 times, will precipitation vacuum filter, vacuum drying, obtain oligochitosan-
Iron complexes；
S2. montmorillonite emulsion is prepared：1000mL pure water immersion 24h, screening, normal are added in 100g montmorillonites ore deposit soil
Under temperature, after ultramicronising process montmorillonite emulsion is obtained；
S3. oligochitosan-ferrum-montmorillonite complex is prepared：Shitosan-the iron complexes prepared by step S1 are dissolved in
In 1.0% hydrochloric acid and 0.5% sulfuric acid mixed solution, add what is be prepared from via step S2 on magnetic stirring apparatuss under room temperature
Montmorillonite emulsion, adds 0.5g HCl to go emulsifying, in being placed on vacuum drying oven, the negative pressure impregnation under pressure limit 30-50kPa
2h, then using vacuum filtration, product is placed in drying baker, and 150 DEG C are dried 5h, obtains final product oligochitosan-ferrum-montmorillonite complex；
Preferably, the mean molecule quantity and average radius of gyration of the poly- gluco-manno sugar that the present invention is used is true by below equation
It is fixed：
N in above formulaAFor Avogadro constant number, n is solvent refraction index, and λ is laser wavelength (nm) in a vacuum,
A is the second dimension profit coefficient,For determination, K is optical constant, and dn/dc is differential refraction index increment, and q is scattering arrow
Amount, c is macromolecular solution concentration.By determining when variable concentrations and angleAnd it is possible thereby to obtain dividing equally again for sample
The relevant molecular parameters such as son amount M, the sharp coefficient A of the dimensions of average radius of gyration R and second.
S4. poly- gluco-manno sugar-oligochitosan-ferrum-montmorillonite complex is prepared：Take oligochitosan-ferrum for being obtained by step S3-
The acetum (1.5%, v/v) that montmorillonite complex is dissolved in, adds poly- gluco-manno sugar by 45 DEG C under the conditions of magnetic agitation, use
It is 8.5 that 10mol/L NaOH adjust pH, and 3h is reacted in then 110 DEG C of oil baths, and reaction terminates to be put into ice-water bath at once, adds after cooling
Volume ratio is 25:24:1 acetone：Ethanol：Isoamyl alcohol mixed liquor, is precipitated, and is first precipitated 3 times with 75% ethanol wash, uses afterwards
Absolute ethanol washing is precipitated 3 times, is drained, and is placed in constant temperature blast drying oven, 37 DEG C, is determined via step using ultraviolet spectrophotometer
The antibacterial antioxidant that rapid S2 is obtained obtains poly- gluco-manno sugar-oligochitosan-ferrum-in the absorbance of 290nm and 420nm
Montmorillonite complex, i.e. antibacterial antioxidant.
Preferably, in the present embodiment, the poly- gluco-manno sugar is xylan class, poly- gluco-manno saccharide or poly- gala
Sugared gluco-manno saccharide；The oligochitosan degree of polymerization between 2～20, molecular weight≤5000Da.
It is highly preferred that the poly- gluco-manno sugar is poly- gluco-manno saccharide or poly- Galactose Glucose manna saccharide, it is described
The oligochitosan degree of polymerization between 7～15, molecular weight≤4500Da.
In order to obtain optimal antibacterial antioxygenic property, for poly- gluco-manno saccharide, it gathers the poly- gluco-manno sugar for adopting
It is right between 10～15, molecular weight≤4000Da.Described poly- gluco-manno sugar derives from Semen Tritici aestivi, Semen Maydiss, Oryza sativa L. or height
The plant fiber of fine strain of millet.
Experimental example
By following experiment, the anti-microbial property of the sponge by made by anti-biotic material used in the present invention is tested,
Method of testing：With reference to national textile industry antibacterial standard FZ/T 01021-92, aimed strain is escherichia coli, golden yellow Fructus Vitis viniferae
Coccus and Salmonella, test result is as shown in table 1；
Experimental procedure is as follows：
S1. clip control sponge sample and antibacterial sponge sample are loaded in conical flask, and sterilization treatment.Cloth specimen specification is
Diameter 5cm, each flask fills fabric block number to absorb 1mL bacterium solutions and not stay residual liquid to be defined；
S2. target bacterium solution is prepared, 1mL bacterium solutions are 1 × 10 containing bacterium number5～2 × 105It is individual,
S3. standby bacterium solution is drawn respectively into 1mL to be added in ready three flasks for filling fabric so as to uniformly knitted
Thing absorbs, and seals bottleneck；
S4. sample；
S5. culture statistics, adds 100mL buffer solution to wash antibacterial toward flask, takes above-mentioned cleaning mixture 1mL and sterilizes
Quantitative measuring pipette draws 1mL, then uses 9mL normal saline dilutions, shaking test tube mix homogeneously to be fabricated to 1:10 diluents.
S6. 1mL diluents are taken and coats agar culture medium, 37 DEG C of culture 24h.
S7. clump count is counted (the culture bacterium colony of 10 times of statistics dilution).
Table 1
| Control sponge (individual mL-1) | Antibacterial sponge (individual mL-1) | |
| Escherichia coli | 4.9×105 | 6.4×102 |
| Salmonella | 3.5×105 | 8.1×102 |
| Staphylococcus aureuses | 5.2×105 | 3.9×102 |
As shown in table 1, the antibacterial effect of the antibacterial sponge that the present invention is used is preferable, under equal condition of culture, two kinds
The clump count of the escherichia coli, Salmonella and staphylococcus aureuses of sponge differs 3 orders of magnitude, and the culture of antibacterial sponge is dilute
The clump count for releasing escherichia coli in liquid, Salmonella and staphylococcus aureuses is respectively 6.4 × 102、8.1×102With 3.9 ×
102Individual mL-1, therefore the sick bed made using the antibacterial sponge also has preferable anti-microbial property, it is ensured that the micro- life in ward
The quantity of thing is in low-level, and the bacterial viruses that can avoid patient itself grow in sick bed, affects the rehabilitation of patient；Can also
Different patients are avoided using causing cross infection after same sick bed, it is also possible to ensure the health of entourage；Therefore it is of the invention
The sick bed with dual sterilizing function there is good market prospect.
Finally it should be noted that above example is only illustrating technical scheme, rather than to present invention guarantor
The restriction of shield scope, although having made to explain to the present invention with reference to preferred embodiment, one of ordinary skill in the art should
Work as understanding, technical scheme can be modified or equivalent, without deviating from the reality of technical solution of the present invention
Matter and scope.
Claims (5)
1. a kind of sick bed with dual sterilizing function, including sick bed main body, mattress and medicated pillow are constituted, it is characterised in that described
Sick bed also includes uv disinfection system, and uv disinfection system includes power cord box, switches set, ultraviolet lamp device box, Universal active
Arm, uviol lamp group；The sick bed main body is made up of rustless steel, and the medicated pillow includes Petiolus Trachycarpi layer and parcel spongy layer, the sick bed
Mattress includes spring, Petiolus Trachycarpi layer and parcel spongy layer.
2. the sick bed with dual sterilizing function according to claim 1, it is characterised in that the switches set includes the time
Controller and uviol lamp gear controller, the number of uviol lamp is 3-5 in the uviol lamp group.
3. the sick bed with dual sterilizing function according to claim 2, it is characterised in that ultraviolet in the uviol lamp group
The number of lamp is 3.
4. the sick bed with dual sterilizing function according to claim 3, it is characterised in that the parcel sponge of the medicated pillow
Layer is made up of anti-biotic material, and the parcel spongy layer of the sick bed mattress is made up of anti-biotic material.
5. the sick bed with dual sterilizing function according to claim 4, it is characterised in that the anti-biotic material includes poly-
Gluco-manno sugar, oligochitosan, zinc ion and montmorillonite are polymerized；The poly- gluco-manno sugar is poly- gluco-manno saccharide or poly-
Galactose Glucose manna saccharide, its degree of polymerization between 10～15, molecular weight≤4000Da；The oligochitosan degree of polymerization 7～
Between 15, molecular weight≤4500Da；Described poly- gluco-manno sugar is fine from the plant of Semen Tritici aestivi, Semen Maydiss, Oryza sativa L. or Sorghum vulgare Pers.
Dimension.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710069884.XA CN106580584A (en) | 2017-02-08 | 2017-02-08 | Sickbed with double disinfecting function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710069884.XA CN106580584A (en) | 2017-02-08 | 2017-02-08 | Sickbed with double disinfecting function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106580584A true CN106580584A (en) | 2017-04-26 |
Family
ID=58586899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710069884.XA Pending CN106580584A (en) | 2017-02-08 | 2017-02-08 | Sickbed with double disinfecting function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106580584A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201528876U (en) * | 2009-06-04 | 2010-07-21 | 王国企 | Traditional Chinese medicine health care mattress |
| CN203417305U (en) * | 2013-08-22 | 2014-02-05 | 陈晓容 | Sickbed with self-disinfection function |
| CN103860342A (en) * | 2012-12-15 | 2014-06-18 | 陈晓容 | Hospital bed capable of conducting sterilizing |
| CN204562661U (en) * | 2015-04-21 | 2015-08-19 | 孟庆清 | Multifunctional electric sickbed |
| CN204744738U (en) * | 2015-05-11 | 2015-11-11 | 上海好易医用制品有限公司 | Medical antibiotic mattress |
| CN205457727U (en) * | 2016-01-04 | 2016-08-17 | 重庆医科大学附属第一医院 | Medical antibiotic pillow |
| CN106691728A (en) * | 2015-11-16 | 2017-05-24 | 于桂菊 | Hospital bed |
-
2017
- 2017-02-08 CN CN201710069884.XA patent/CN106580584A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201528876U (en) * | 2009-06-04 | 2010-07-21 | 王国企 | Traditional Chinese medicine health care mattress |
| CN103860342A (en) * | 2012-12-15 | 2014-06-18 | 陈晓容 | Hospital bed capable of conducting sterilizing |
| CN203417305U (en) * | 2013-08-22 | 2014-02-05 | 陈晓容 | Sickbed with self-disinfection function |
| CN204562661U (en) * | 2015-04-21 | 2015-08-19 | 孟庆清 | Multifunctional electric sickbed |
| CN204744738U (en) * | 2015-05-11 | 2015-11-11 | 上海好易医用制品有限公司 | Medical antibiotic mattress |
| CN106691728A (en) * | 2015-11-16 | 2017-05-24 | 于桂菊 | Hospital bed |
| CN205457727U (en) * | 2016-01-04 | 2016-08-17 | 重庆医科大学附属第一医院 | Medical antibiotic pillow |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kean et al. | The comparative efficacy of antiseptics against Candida auris biofilms | |
| US9744270B2 (en) | Nanocrystalline cellulose hydrogels for inhibition of bacterial adhesion | |
| US8721963B2 (en) | Cold sterilization of tissue engineering scaffolds with compressed carbon dioxide | |
| KR20090012250A (en) | Antiseptic-containing silicone elastomers | |
| US20170167073A1 (en) | Antimicrobial textiles and methods for production of the same | |
| Boggione et al. | Preparation of polyvinyl alcohol hydrogel containing bacteriophage and its evaluation for potential use in the healing of skin wounds | |
| CN100490908C (en) | The medical use anti-infection polymeric material and its preparation method | |
| Dizman et al. | Antibacterial fluoromicas: a novel delivery medium | |
| Ismail et al. | Mohd. Hasmizam Razali, Antibacterial Study of Gellan Gum (GG) Film Incorporated Norfloxacin | |
| Kasuga et al. | Bactericidal activities of woven cotton and nonwoven polypropylene fabrics coated with hydroxyapatite-binding silver/titanium dioxide ceramic nanocomposite “Earth-plus” | |
| CN106580584A (en) | Sickbed with double disinfecting function | |
| Nuryastuti et al. | Ica-status of clinical Staphylococcus epidermidis strains affects adhesion and aggregation: a thermodynamic analysis | |
| CN111424427A (en) | Non-dissolution type antibacterial finishing agent and preparation method thereof | |
| SAMET et al. | Evaluation of biofilm-forming capabilities of urinary Escherichia coli isolates in microtiter plate using two different culture media | |
| CN112189670A (en) | Non-corrosive, non-irritant and disinfectant sanitary wet tissue and manufacturing method thereof | |
| CN104293661B (en) | A kind of quick antibacterial test method and kit | |
| JPH02306905A (en) | Antimicrobial agent | |
| CN105560271B (en) | Chitosan Betagen Solution and its manufacture craft | |
| CN104358123B (en) | A kind of preparation method of propionyloxyethyl trimethyl ammonium chloride chitin fiber | |
| CN106822077A (en) | A kind of compound acidulant and its application | |
| CN112972281A (en) | Disinfectant-grade hand sanitizer containing salicylic acid microcapsules and preparation method thereof | |
| CN106551950A (en) | A kind of phosphorus magnesium crystal whisker materials with broad-spectrum antibacterial action | |
| Reeves | Advantages and disadvantages of an in-vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin | |
| CN111533835A (en) | Curable quaternary ammonium salt with long-acting antibacterial function and application thereof | |
| Saraswathy et al. | Bactericidal Activity of Superabsorbent Polymer Granules for Their Applications in Respiratory Fluid Solidification Systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
| RJ01 | Rejection of invention patent application after publication |